EUCTR2020-001387-28-NL进行中（未招募）1 期
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathology.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- Suspicion for PCa (e.g. elevated PSA, suspicious rectal examination)
- •- Males = 18 years
- •- ECOG 0-1
- •- Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •- Prostate biopsy in the last 6 months
- •- History of prostate cancer
- •- Second active malignancy
- •- Any prior surgery in the pelvic area that might interfere with the scans (e.g. hip replacement surgery)
- •- Any medical condition that in the opinion of the investigator will affect patients’ clinical status when participating in this trial.
- •- Contra-indications for mpMRI or PET: claustrophobia or inability to lay still for the duration of the exam.
研究者
相似试验
已完成
2 期
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathologyProstate cancerNL-OMON49534Radboud Universitair Medisch Centrum75
进行中（未招募）
1 期
PSMA-PET/CT for prostate cancerEUCTR2017-003461-96-BEGhent University Hospital72
招募中
不适用
PSMA PET prostate cancer registration studyProstate cancerNL-OMON28640-
已完成
1 期
18F-PSMA-1007 PET Imaging to Detect Primary Prostate CancerProstate CancerNCT04487847Radboud University Medical Center75
尚未招募
不适用
Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialProstate CancerNCT06489496Alberta Health services1,000